Matthew J. Hawryluk's most recent trade in Gritstone Bio Inc was a trade of 180,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gritstone Bio Inc | Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 19,149 | 323,190 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 15 May 2024 | 9,259 | 313,931 (0%) | 0% | 0.7 | 6,929 | Common Stock |
| Predictive Oncology Inc | Matthew J. Hawryluk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 2,368 | 9,488 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | J. Matthew Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Matthew J. Hawryluk | EVP, CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 35,000 | 286,880 (0%) | 0% | 0 | Common Stock |